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ABSTRACT 
Mindfulness-based therapies (MBT) have been shown to be efficacious in treating 
internally-focused psychological disorders (e.g., depression), however it is still unclear 
whether MBT provide improved functioning and symptom relief for individuals with 
externalizing disorders, including ADHD. In order to clarify the literature on the efficacy 
of MBT in treating ADHD and to guide future research, an effect size analysis was 
conducted. A systematic review of studies published in PsycINFO, PubMed, and Google 
Scholar was completed from the earliest available date until December 2014. A total of 
eight studies were included in the analysis of inattention and the overall effect size was 
d= -.72. A total of seven studies were included in the analysis of hyperactivity-
impulsivity and the overall effect was calculated at d= -.60. Findings related to changes in 
executive functioning pre- and post-intervention were equivocal. Results of this study 
highlight the possible benefits of MBT in reducing symptoms of ADHD. 
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I. LITERATURE REVIEW 
Introduction 
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent disorder – 
one of the most common disorders of childhood (Centers for Disease Control and 
Prevention [CDC], 2015). Given that the symptoms of ADHD result in significant 
impairment in multiple areas of functioning, developing new treatments has important 
implications for the quality of life of individuals who suffer from ADHD.  ADHD is most 
often treated with medication and/or psychosocial treatments, however in recent years, 
mindfulness-based therapies (MBT) have been introduced as a potential treatment for 
children and adults with ADHD (Hayes, 2004). Although research has demonstrated 
MBT to be a moderately effective treatment for internally-focused disorders (Khoury et 
al., 2013), it is still unclear whether MBT can provide improved functioning and 
symptom relief for individuals with externalizing disorders such as ADHD.  
Using MBT as a treatment for ADHD offers a potentially successful 
psychotherapeutic treatment to be used in conjunction with medication therapy, or as an 
alternative treatment, which would be particularly important for individuals who suffer 
adverse side effects from ADHD medication, or for those who are unwilling to consider 
ADHD medications. The goal of the current study is to determine if individuals who have 
been diagnosed with ADHD and receive MBT experience positive outcomes, such as a 
reduction in ADHD symptoms (hyperactivity-impulsivity and inattention) and improved 
executive control; thus, determining the potential benefits of mindfulness-based 
intervention on individuals diagnosed with ADHD. 
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 The purpose of this chapter is to review the literature on ADHD and the current 
treatments for individuals diagnosed with ADHD, to define mindfulness and how 
mindfulness-based therapies have been integrated in the treatment of psychological 
disorders, and lastly to present support for how mindfulness-based therapies may be 
effective in reducing ADHD symptoms and improve functioning in individuals diagnosed 
with ADHD.  
Attention-deficit/Hyperactivity Disorder 
 Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent 
neurobehavioral disorder, which manifests as developmentally-inappropriate pervasive 
and persistent inattention, hyperactivity, and impulsivity that are impairing and present in 
at least two settings (American Psychiatric Association, 2013). ADHD impacts 
approximately 5-7% of children and adolescents worldwide and 4.4% of adults (APA, 
2013; Polancyzk, de Lima, Horta, Biederman, & Rhode, 2007). Although symptoms are 
typically first noted in childhood, between 46% and 66% of these individuals continue to 
experience significant impairment into adolescence and early adulthood (Barkley, 
Fischer, Smallish, & Fletcher, 2002). Often, these symptoms result in significant 
difficulty in multiple areas of functioning, including education (Mannuzza, Klein, Bessler 
et al., 1993), employment (Mannuzza, Klein, Bessler et al., 1993), and strained romantic 
and familial relationships (Bagwell, Molina, & Pelham et al., 2001; Johnston & Mash, 
2001). Furthermore, the symptoms commonly involve significant comorbid 
psychopathology (e.g. Cherkasova et al., 2013).  
 Despite the heterogeneity of symptoms expressed by children and adults 
diagnosed with ADHD, two primary symptom groups are diagnostic: inattention and poor 
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behavioural control, expressed as hyperactivity and impulsivity. The clinical presentation 
of an individual with ADHD changes across the lifespan and is largely dependent on the 
individual’s current developmental stage (Cherkasova, Sulla, Dalena, Ponde, & 
Hechtman, 2013). 
 Difficulty sustaining attention occurs in tasks that require a large amount of self-
regulation and task- or goal-directed persistence (Barkley, 1997). This difficulty 
sustaining attention is not a problem of processing information, rather an inability to 
inhibit and control external and internal stimuli that interfere with the executive functions 
that assist in self-regulated persistence (Barkley, 1997). Children with ADHD may be 
easily distracted, have problems with organizing tasks, and have difficulties completing 
schoolwork, especially when it requires a great deal of sustained mental effort. 
 Individuals diagnosed with ADHD may also have difficulties related to over-
activity and poor impulse control (Barkley, 1998). Although the generalized overactivity 
often fades by adulthood, impulsive behaviour may remain stable (Moffitt et al., 2011). 
Children with ADHD may appear impatient, interrupt conversations/activities, and 
appear emotionally unrestrained. As a result of their difficulties with self-regulation, they 
may rush through schoolwork and make careless errors. Sitting still for long periods of 
time, fidgeting, and having trouble with quiet tasks are all hallmark behaviours associated 
with ADHD.  
 Symptoms of inattention and hyperactivity in early childhood are highly 
positively associated with one another. However, typically the symptoms associated with 
hyperactivity decrease with age, and symptoms of inattention tend to become more 
evident in their manifestation throughout the life span (Galera et al., 2012). For 50% of 
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preschool children with ADHD, the ADHD symptoms will persist into school age and 
approximately 50-70% of those persist across the lifespan into adulthood (Miller, Miller, 
Newcorn, & Halperin, 2008). ADHD in school-aged children interferes with academic 
performance, and peer and familial relationships (Barkley, 2006). During this time, 
symptoms of inattention continue to increase in severity, as hyperactivity decreases 
(Lahey et al., 2004). Generally, symptoms of inattention decline slower than 
hyperactivity and impulsivity in adolescence and adulthood ADHD (Biederman, Mick, & 
Faraone, 2000; Molina et al., 2009). A recent meta-analysis determined that while not all 
cases of ADHD will warrant a clinical diagnosis in adulthood, it is estimated that around 
65% will continue to have impairments resulting from persisting symptomology 
(Faraone, Biederman, & Mick, 2006).  Longitudinal studies investigating the persistence 
of ADHD into adulthood suggest that the proportion varies from 15% (Faraone, 
Biederman, & Mick, 2006) and up to 58% (Biederman et al., 2006).  
 Many factors contribute to the development of ADHD, and continue to predict 
ADHD persistence and impairment throughout the lifespan. Persistence of ADHD from 
childhood into adolescence and adulthood is predicted by severity of childhood ADHD 
symptoms and level of impairment in childhood; the presence of comorbid disorders (e.g. 
ODD, CD, anxiety disorders); intellectual functioning; level of behavioural problems; 
parental psychopathology; and familial factors, such as parenting style that affects the 
emergence of comorbid disorders such as ODD, CD, and problems with emotional 
adjustment (Barkley, et al., 2008; Biederman, Faraone, Milberger, Curtis, et al., 1996; 
Biederman, Petty, Clarke, Lomedico, & Faraone, 2011; Molina, et al., 2009; Swanson et 
al., 2007).   
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Etiology  
 While the etiology of ADHD continues to be studied by psychological and 
medical researchers, it is generally believed to be a result of the interaction of genetic and 
environmental factors (Nikolas & Burt, 2010). Behavioural genetic studies employing 
twin samples and adoption studies have been used to estimate the genetic influences on 
ADHD. These studies have implicated a high degree of heritability – up to 80% (Bobb, 
Castellanos, Addington, & Rapoport, 2006; Faraone & Biederman, 1998). Molecular 
genetic association studies have also shown that there are many genetic polymorphisms 
that contribute to the development of ADHD (Beaver, Nedelec, Rowland, & 
Schwartz,2012), including DRD4, DAT1, and DATI (genes involved in the dopaminergic 
system), HTR1B (a gene involved in the serotonergic system), and SNAP25 (a gene 
involved in the synthesis of a protein important for the development of axons, the release 
of neurotransmitters, and synaptic plasticity; Coghill & Banaschewski, 2009). Based on 
current studies, it is likely that multiple genes-of-risk are involved. 
There are also neuroanatomical findings related to ADHD. Imaging studies of 
individuals with ADHD reveal dysfunctions in regions belonging to multiple neuronal 
networks involved in higher-level cognitive and sensorimotor functions (Cortese et al., 
2012). Structural imaging studies show that individuals with ADHD commonly have 
cortical thinning and reduced dimensionality of the prefrontal cortex, caudate nucleus, 
corpus callosum, and cerebellar vermis (Valera, Faraone, Murray, & Seidman, 2007). 
Recent meta-analytic review of fMRI data revealed that children with ADHD had 
hypoactivation in the ventral attention and frontoparietal networks and hyperactivation in 
the ventral attention, somatomotor, and default mode network relative to comparison 
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subjects (Cortese et al., 2012). In adults with ADHD, hypoactivity occurred almost 
predominantly in the frontoparietal network (Cortese et al., 2012), an area of the brain 
imperative to attention (Ptak, 2012). The notion that ADHD is a disorder of dysfunctions 
in large brain networks has led to the idea that these alterations in brain structure and 
function may influence the diverse display of neurocognitive deficits that are 
demonstrated in children and adults with ADHD (Halperin, Bedard, & Curchack-Lichtin, 
2012).  
 Beyond the genetic predisposition involved in the development of ADHD, certain 
prenatal and perinatal environmental factors increase the risk for ADHD. Maternal 
nicotine use (Linnet et al., 2003), alcohol use (Mick, Biederman, Faraone, Sayer, & 
Kleinman, 2002), and drug use during pregnancy (Accornero et al., 2007), as well as 
exposure to various chemicals/contaminants (Nigg, 2005) can increase the risk of the 
disorder. Further, maternal stress (Linnet, et al., 2003) and poor maternal nutrition during 
pregnancy (Vermiglio et al., 2004) can also increase the likelihood of developing the 
disorder. Not all children exposed to these environmental factors develop ADHD, thus 
genetics may predispose individuals to increased risk for poor outcomes. Postnatal 
environmental factors also exist, such as parenting style and socioeconomic status (Nigg, 
Nikolas & Burt, 2010).  
Diagnosis 
 There is not a definitive test used to diagnose ADHD. Current diagnostic criteria 
for ADHD are from the Diagnostic and Statistical Manual of Mental Disorders (APA, 
2013), which is currently in its fifth version (DSM-V). ADHD symptoms are divided into 
two domains – inattention, and hyperactivity-impulsivity. In order to qualify for a 
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diagnosis of ADHD children must endorse at least six symptoms from either or both of 
the categories listed in the DSM-V. The newest edition of the DSM clarifies the 
diagnostic criteria to be used in diagnosing adults with ADHD: individuals over the age 
of 17 only need evidence of five or more symptoms in at least one domain but symptom 
onset and evidence of impairment must be present prior to the age of 12 years. The 
assessment of ADHD requires the clinician to obtain rating scales from multiple 
informants (e.g., self-, parental-, and teacher-reports) that demonstrates impairment 
across multiple settings (e.g., home, school, work). Clinical interviews with the patient 
and informants can also provide important information, as well, when resources permit, a 
direct observation of the child and their behaviour is advantageous. Psychological testing 
is only indicated when there are concerns about comorbidities (Barkley, 2014). 
Comorbid Conditions 
 Diagnosis of ADHD is often complicated by psychiatric and neurological 
comorbid conditions. Approximately 67-80% of children and 80% of adults diagnosed 
with ADHD also have at least one comorbid condition and up to 50% of these individuals 
will have more than one comorbid disorder (Barkley, Murphy, & Fischer, 2008). ADHD 
is highly comorbid with externalizing disorders such as ODD and CD, and internalizing 
disorders such as anxiety and depression (Jensen et al., 2001). Comorbid behavioural 
problems such as ODD and CD in childhood ADHD is a predictor of comorbidity in 
adulthood ADHD (Cherkosava et al., 2013) and are associated with social relationship 
problems and psychopathology such as substance use, and mood and personality 
disorders (Barkley, Murphy, & Fischer, 2008; Biederman, Faraone, Milberger, Guite et 
al., 1996; Biederman et al., 2008). Other common comorbid disorders include learning 
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disabilities, problems with academic achievements, motor coordination problems, sleep 
disorders, and substance abuse (Brown, 2009; Tomblin & Mueller, 2012). These 
comorbid conditions vary across the lifespan in individuals diagnosed with ADHD 
(Cherkosava et al., 2013).  Like ADHD, these comorbidities are likely to persist into 
adolescence and adulthood (Kessler et al., 2006); furthermore, those with comorbid 
disorders are often more impaired (Cherkosava et al., 2013). 
 Adults who grew up with ADHD tend to have psychiatric comorbidities, 
relationship and marital problems, and poorer academic achievement, job rank and 
performance, and are more likely to engage in risky sexual behaviour and criminal 
behaviour (Barkley, Murphy, & Fischer, 2008; Biederman, Faraone, Milberger, & Guite, 
1996; Biederman et al., 2006; Klein et al., 2012; Mannuzza, Klein, & Moulton, 2008; 
Molina, et al., 2009). Common psychiatric comorbidities in adulthood ADHD are 
antisocial personality disorders and substance misuse (Barkley, et al., 2008; Biederman, 
et al., 2006; Klein, et al., 2012; Mannuzza, et al., 1998; Molina, et al., 2009).  
Treatment 
 Treatments available for children with ADHD aim to reduce symptoms and 
improve functioning across settings. The most commonly advocated treatments include 
medication, behavioural intervention, and parent training. Over the past four decades, 
psychostimulant medications have become among the most frequently prescribed 
medications for all childhood conditions, including antibiotics and asthma medications 
(Mayes & Rafalovich, 2007). Stimulant treatment has been reported to improve 
symptoms in individuals with ADHD; it is reported that 70-80% of children with ADHD 
experience improvements in their symptoms (DuPaul, Barkley, & McMurray, 1991; 
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Multimodal Treatment Study of Children with ADHD Cooperative Group: MTA, 1999). 
Further, research has shown that children diagnosed with ADHD who take 
psychostimulant medication score higher on neuropsychological measures of attention 
and verbal learning (Biederman et al., 2008). However, a small percentage of individuals 
who are prescribed medication to treat ADHD symptoms have adverse side effects such 
as sleep problems and loss of appetite (MTA, 1999; Graham & Coghill, 2008; Martin, 
2007).  
Often, adjunctive therapies such as behavioural interventions (e.g. antecedent-
based strategies, contingency management techniques, social-skills straining), parent 
skills training, cognitive-behavioural therapy, and more recently mindfulness-based 
therapies are used in conjunction with psychostimulants. Combined treatment has been 
shown to reduce ADHD symptoms and improve other functional domains (e.g., 
externalizing and internalizing behaviours) more than behavioural treatment alone (MTA, 
1999). Research has shown that combined medication and behavioral intervention 
provides the most effective symptom relief for individuals diagnosed with ADHD (Smith, 
Barkley, & Shapiro 2006). Thus, combined treatment is often utilized to provide 
improved symptom relief as well as improved overall functioning for children and adults 
with ADHD, particularly for adults who are less effectively treated with medication 
therapy alone (Spencer, Biederman, & Wilens 2000). 
 Behaviour therapy. Behavioural interventions for children with ADHD include 
antecedent-based strategies, contingency management techniques, and self-management 
strategies (DuPaul & Weyandt, 2006).  Recent meta-analysis supports the effectiveness 
of behavioral based therapies for the treatment of ADHD (Fabiano et al., 2009). 
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Behavioural interventions for ADHD were developed from theories related to classical 
conditioning, operant conditioning, and social learning (Kolivas, Riordan, Gross et al., 
2008). Because ADHD is often described as a developmental delay in internal self-
regulation of behaviour and motivating goal-directed behaviour, these interventions work 
to provide externally represented information to guide behaviour, which enhances 
motivation (Mash & Barkley, 2006). Children with ADHD typically display symptoms in 
multiple settings. Thus, it is imperative that not only the parents but also the child’s 
teacher incorporate these behavioural interventions; these interventions have been shown 
to improve the functioning of children with ADHD across multiple settings (e.g., home 
and school; Fabiano et al., 2009). Research has shown that, although behavioural 
interventions typically do not decrease core symptoms of ADHD, they often improve the 
child’s overall functioning by decreasing disruptive behaviour and improve the social 
skills and relationships of the child (Roman, 2010). 
 Parenting training skills. Behavioural parent training (BPT) has been shown to be 
effective for children with ADHD (Chronis, Chacko, Fabiano, Wymbs, & Pelham, 2004; 
Sonuga-Barke, Daley, & Thompson, 2002; Sonuga-Barke, Daley, Thompson, Laver-
Bradbury & Weeks, 2001). Most often, BPT consists of training parents in general 
contingency management strategies: providing reinforcements following appropriate 
behaviour and punishment following inappropriate behaviour (Mash & Barkley, 2006). 
One problem associated with BPT of children with ADHD is the high heritability of 
ADHD; thus, many parents who receive the training may have ADHD themselves and 
this may limit the success of the BPT for the child with ADHD (Sonuga-Barke et al., 
2002). 
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 Cognitive-behavioural therapy. Treatment of ADHD with cognitive-behavioural 
therapy (CBT) involves training individuals to self-instruct on how to approach a task, 
give themselves self-statements of evaluation, and self-reinforcement upon completion of 
a task (Mash & Barkley, 2006). CBT has previously shown some promise for children 
with ADHD (Kendall & Braswell, 1985; Meichenbaum & Goodman, 1971) but these 
effects were somewhat limited (Bloomquist, August, & Ostrander, 1991; Braswell et al., 
1997). In contrast, meta-cognitive therapies, which employ cognitive behavioural 
strategies has been used in adults with ADHD effectively (Solanto, Marks, Wasserstein, 
Mitchell, & Abikoff, 2010).  
 Coaching. Coaching is an intervention that has recently increased in popularity 
for treating adults with ADHD.  Coaching as an intervention focuses on goals, strategies 
for meeting goals, and emphasizes the accountability of the individual with ADHD 
(Knouse, Cooper-Vince, Sprich, & Safren, 2008). It uses psychoeducation to help adults 
and older adolescents with ADHD to improve functional skills to cope with the 
behavioral, emotional, and cognitive difficulties associated with ADHD (Kubik, 2010). 
Unlike in CBT, coaching takes a specific and action-oriented approach to meeting 
concrete goals (Knouse et al., 2008). The psychoeducation of potential negative outcomes 
associated with ADHD is integrated with developing and implementing new strategies to 
cope with these outcomes in everyday life.  
 Mindfulness interventions. Over the last fifteen years, mindfulness-based 
therapies (MBT) have been introduced to help with symptom relief of children and adults 
with ADHD (Hayes, 2004). In these mindfulness interventions, the internal experiences, 
thoughts, feelings, and bodily sensations of the individual have been integrated into the 
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intervention (Greco & Hayes 2008). Acceptance and mindfulness-based therapies seek to 
bring awareness to these internal processes in order to reduce their impact on the 
individual’s functioning (Greco & Hayes, 2008). Recent research suggests that MBT may 
improve core symptoms of ADHD, with improvements in both attention and aspects of 
executive control, particularly in adults (Zylowska et al., 2008). Functional and structural 
imaging studies also suggest that patterns of hypoactivity in frontal regions of the brain 
were detected in individuals with ADHD (Dickstein, Bannon, Castellanos, & Milham, 
2006), and activation of many of these regions can be enhanced in mindful meditators 
(Manna et al., 2010), suggesting a means by which MBT may successfully improve 
symptoms of ADHD (Grant et al., 2013).   
Mindfulness 
 The concept of mindfulness, rooted in ancient Buddhist practice, has proliferated 
over that past 2,500 years in many Asian countries, but it was not until more recently that 
there has been an increased interest in mindfulness throughout the Western world (Langer 
& Moldoveanu, 2000). In the 1970’s, Western practitioners adopted a particular interest 
in the utility of meditative and contemplative practices and their clinical applications, 
particularly for individuals with chronic pain disorders, high levels of stress, and chronic 
disease processes. Over the last several decades the clinical community has begun to 
adopt the concept into an integrative approach to healthcare and wellness promotion, 
which focuses on attitude, behaviour, and cognitive-affective processing and how this can 
affect functional outcomes, outside of a religious context.  
 The ancient Buddhist meditation techniques from which mindfulness originates 
facilitated individual insight, and promoted awareness to the present moment and to the 
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individual’s psychological responses (Hart, 1987). In Buddhist tradition, mindfulness was 
developed as part of an individual’s path to relieve personal suffering (Thera, 1962; 
Silananda, 1990). As a clinical component, mindfulness, which is the act of self-
regulating attention in a non-judgmental way to the present moment (Zylowska et al., 
2008), can lead to a greater sensitivity to the environment, openness to information, new 
ways of perceiving, and increased awareness (Langer & Moldoveanu, 2000). Clinical 
mindfulness training increases an individual’s awareness and brings acceptance of 
experiences involving thoughts, emotions, physiological sensations, and events external 
to the individual (Baer, 2003; Cash & Whittingham, 2010). 
 In contemporary psychology, mindfulness has been used to increase awareness 
and teach the individual to identify and respond to the physiological and psychological 
processes that are involved in maladaptive behaviours and emotions (Bishop et al., 2004). 
Several researchers have attempted to conceptualize models of mindfulness. For example, 
some researchers believe that the emotional and attentional components of mindfulness 
create a unidimensional construct (i.e. Brown & Ryan, 2003). Whereas others have 
proposed a two-dimensional model that involves an attentional component and a second 
emotion regulation factor (Bishop et al., 2004). The two-factor model of mindfulness 
proposed that the ability to focus in the present moment experience and the act of doing 
so openly, and with curiosity and acceptance are separable factors that both contribute to 
mindfulness (Bishop et al, 2004). Bishop and colleagues (2004) proposed that 
mindfulness is composed of two components and operationalized as such: 
(1) The first component involves the self-regulation of attention so that it is 
maintained on immediate experience, thereby allowing for increased 
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recognition of mental events in the present moment.  
(2) The second component involves adopting a particular orientation towards 
one’s experiences in the present moment, and orientation that is characterized 
by curiosity, openness, and acceptance (Bishop et al., 2004, p. 232) 
Therapeutic Effects of Mindfulness 
Due to the recent interest of mindfulness as a potential alternative therapy to a 
variety of different psychological disorders, several different MBT have been developed. 
The first therapy to introduce mindfulness into mainstream medicine was a program 
developed by Dr. Jon Kabat-Zinn, Mindfulness-based Stress Reduction (MBSR; 1990), at 
the University of Massachusetts. MBSR was originally developed as a program to 
manage chronic pain, but has since been validated for use with many different clinical 
and subclinical populations. MBSR is an 8-week psychoeducational program that 
consists of weekly 2.5-hour classes of guided mindfulness meditation. Participants are 
expected to do 45-60 minutes of home practice each day. There is also a day-long retreat 
between the 6th and 7th week of training. The therapy is led in a group format. 
Participants are taught meditation techniques that may be applied to tasks of daily living 
such as driving, eating, and interacting with others (Salmon et al., 2004). MBSR is not a 
goal-directed therapy; the purpose of MBSR is to teach the participant to be present and 
aware in their moment-to-moment life (Kabat-Zinn, 1982).   
 A strong interest in the clinical utility of mindfulness resulted from the 
development of MBSR. MBSR is now widely used and has been shown to effectively 
reduce stress and increase emotional well-being (William, Kolar, Reger, & Pearson, 
2001), has effectively been used to treat emotional and behavioural disorders (e.g. Kabat-
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Zinn, 1982; Teasdale et al., 2000), and reduce psychological problems often comorbid 
with medical illness (Reibel, Greenson, Brainard, & Rosenzweig, 2001; Speca, Carlson, 
Goodey, & Angen, 2000; Carlson, Ursuliak, Goodey, Angen, & Speca, 2001) 
 Various other programs have been developed based on modifications of the 
MBSR program, such as Mindfulness-based Cognitive Therapy (MBCT: Segal, 
Williams, & Teasdale, 2002), which utilizes mindfulness meditation in conjunction with 
cognitive therapy. It was designed to decrease relapse rate in individuals with recurrent 
depression (Teasdale et al., 2000). Mindfulness training is also a central component to 
therapies such as Dialectical Behaviour Therapy (DBT: Linehan, 1993, p. 114), which 
utilizes mindfulness meditation and has been shown to reduce suicidality and self-harm in 
patients with borderline personality disorder (Linehan, Armstrong, Saurez, Allmon, & 
Heard, 1991) and Acceptance and Commitment Therapy (ACT; Hayes, Strosahl, & 
Wilson, 1999), which promotes psychological flexibility by integrating mindfulness 
training into therapy and has been shown to be effective in treating disorders such as 
depression and anxiety (Forman, Herbert, Moitra, Yeomans, & Gellar, 2007). But, 
regardless of the specific protocol being used, each program’s main focus is teaching the 
participants to become more mindful, accepting, and aware. Individuals are encouraged 
to be active participants in the process and take responsibility for their own outcomes 
(Kabat-Zinn, 1982). 
Assessment of mindfulness 
 Several instruments have been created and psychometrically validated to measure 
the construct of mindfulness. Mindfulness is predominantly measured using self-report 
questionnaires. Most scales have been validated by means of confirmatory factor analysis 
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and have shown good psychometric properties (Sauer, Walach, Schmidt, Hinterberger et 
al., 2013). The current study will not explore the changes in mindfulness via meta-
analysis; therefore a review of each existing mindfulness scale and the differences 
between them is beyond the scope of this paper (see Sauer et al., 2013 for a 
comprehensive review of each scale and each scales psychometric properties). The 
existing mindfulness scales are the most common process for assessing mindfulness, 
however, several alternatives to self-report measures exist.  
 Researchers have begun to use qualitative approaches to assessing mindfulness, 
although this approach is in its infancy. For example, some researchers have investigated 
the possibility of using qualitative interview data to acquire a more in-depth analysis of 
an individual’s level of mindfulness and can be used as an explorative approach to 
complement quantitative analyses (Sauer et al., 2013). For example, Collins and 
colleagues (2009) developed a language-based measure of mindfulness by which 
mindfulness is assessed via the number of words that an individual uses that are related to 
the concept of mindfulness.  
 An individual’s level of mindfulness can also be assessed through observation by 
an unbiased observer. This approach assumes that an individual’s level of mindfulness 
can be assessed externally by a trained mindfulness expert on the bases of their own 
experiences and the trajectory of their own mindfulness development (Sauer et al., 2013). 
This approach has not been used within a research context; it is most commonly used in 
Buddhist practice (Sauer et al., 2013).    
 Lastly, cognitive tests such as standard tests of attention have also been 
investigated as a means of objectively assessing mindfulness (Fan et al. 2005; Jha, 
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Krompinger, & Baime, 2007; Tang and Posner 2009; Zeidan et al. 2010). Researchers 
have begun investigating the biological and neuronal correlates of mindfulness. Evidence 
exists that shows lower cortisol levels (Matousek, Pruessner, & Dobkin, 2011) and 
increased cortical thickness in areas active during meditation (Ott et al., 2011) in 
individuals who practice mindfulness. Although these variables are sensitive to 
mindfulness, they should not be equated. However, they do provide valuable insight into 
the nature of mindfulness. 
Neurobiological Correlates of Mindfulness 
 Functional and structural imaging studies suggest that patterns of neural 
functioning and brain structure are altered by mindfulness training (Davidson et al., 2003; 
Ott et al., 2011; Holzel et al. 2008). Thus, the therapeutic effects of MBT could be a 
result of underlying neurobiological changes that occur following mindfulness training. 
Brain imaging studies have shown that cortical areas activated by mindfulness activities 
are actually larger in individuals who practice mindfulness compared to those who do not 
practice mindfulness (Ott et al., 2011). Furthermore, research has demonstrated greater 
cortical thickness (Lazar et al., 2005) and increased grey matter concentration in 
individuals who practice mindfulness meditation (Holzel et al., 2008).  
Mindfulness and ADHD 
 Recent research suggests that MBT may improve core symptoms of ADHD, with 
improvements in both attention and executive control (Zylowska et al., 2008). Functional 
and structural imaging studies also suggest that patterns of hypoactivity in frontal regions 
of the brain were detected in individuals with ADHD (Dickstein et al., 2006), and 
activation of many of these regions can be enhanced in mindful meditators (Manna et al., 
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2010), suggesting a means by which MBT may successfully improve symptoms of 
ADHD (Grant et al., 2013). However, some of this earlier work has been criticized due to 
small sample sizes and exploratory analyses.  
 Researchers have asked the question of whether ADHD and mindfulness overlap 
because sustained attention is imperative to mindfulness as well as positive outcomes 
related to ADHD (Smalley et al., 2009). Research has shown that mindfulness training 
improves attentional capacity (Lutz et al., 2009; Tang et al., 2007) and decreases 
impulsivity (Kozasa et al., 2012) in small samples, impairments typical in individuals 
with ADHD. Recent research has shown that participants trained in mindfulness can 
develop greater ability to focus and self-regulate. Research has also shown that 
individuals with ADHD score lower on measures of trait mindfulness than individuals 
who have not been diagnosed with ADHD (Smalley et al., 2009). Furthermore, in a study 
conducted on adults with ADHD, they noted the topic of mindfulness as important for 
their improved functioning (Philipsen, Richter, Peters, Alm, Sobanski et al., 2007). 
 Studies measuring changes in attentional capacity following mindfulness training 
report that changes in conflict attention occur quite rapidly (Tang et al., 2007), which is 
defined as attention that is important to self-regulation (Posner & Rothbart, 1998), and is 
involved in the inhibition of automatic responses. Studies report that individuals with 
ADHD have decreased conflict attention (Loo et al., 2007) and mindfulness training has 
been shown to increase this construct (Tang et al, 2007). Brain imaging studies of conflict 
attention show involvement of the prefrontal cortex (Posner & Rothbart, 1998) and 
imaging studies of ADHD and mindfulness both show involvement of the same 
prefrontal areas (Davidson et al, 2003; Giedd, Blumethal, Molloy, & Castellanos, 2001; 
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Holzel et al., 2011; Lazar et al., 2005). The aforementioned research suggests that 
mindfulness training may be effectively used to improve functioning and reduce 
symptomology in individuals with ADHD.  
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II. THE PRESENT STUDY 
As previously described, ADHD is most often treated with medication and/or 
psychosocial treatments. However, in recent years, mindfulness-based therapies (MBT) 
have been introduced as a potential treatment for children and adults with ADHD (Hayes, 
2004) because mindfulness training has been shown to increase attentional capacity 
(Zylowska et al., 2009). And although research has demonstrated MBT to be a 
moderately effective treatment for depression, stress, anxiety, and other psychological 
problems (Khoury et al., 2013), it is still unclear whether MBT can provide improved 
functioning and symptom relief for individuals with externalizing disorders such as 
ADHD. 
A number of studies have begun to address this question, but samples are 
relatively modest. The results of these studies suggest that MBT reduces reported 
symptoms of ADHD and improves scores on measures of associated neurocognitive 
deficits. However, a recent study on adolescents with ADHD showed that although 
changes on parent-rated inattention occurred, on self-reported measures of ADHD 
symptoms no statistical significance was reported for inattention, and further, there was 
no statistically significant difference at pre- and post-intervention for hyperactivity-
impulsivity ratings (Haydicky, 2013). In the same study, MBT was shown to significantly 
reduce parent-rated conduct problems and peer relational problems in adolescents with 
ADHD (Haydicky, 2013), demonstrating the therapies benefits to the psychosocial 
deficits often associated with ADHD.  
Given that ADHD symptoms result in such significant impairment in multiple 
areas of functioning, developing new treatments has important implications for the 
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quality of life of individuals, and the families of individuals, who suffer from ADHD. 
Using MBT as a treatment for ADHD offers a potentially successful psychotherapeutic 
treatment to be used in conjunction with medication therapy, or as an alternative 
treatment, which would be particularly important for individuals who suffer adverse side 
effects from ADHD medication, or for those who are unwilling to consider ADHD 
medications. In order to address this question an effect-size analysis was conducted on 
studies investigating the effects of MBT on ADHD to determine the size of the treatment 
effect. To this author’s knowledge, there are no published meta-analytic studies of MBT 
for individuals with ADHD.  
 Thus, the purpose of the present study was an investigation into the potential 
benefits of mindfulness-based interventions on individuals diagnosed with ADHD. In 
order to accomplish these research goals, a meta-analysis was conducted to determine if 
individuals who have been diagnosed with ADHD and receive MBT experience positive 
outcomes, such as decreased hyperactivity-impulsivity and increased attentional capacity 
that are examined by pre-post effects. Further, a qualitative review of how MBT may 
effect executive functioning in individuals diagnosed with ADHD was also conducted. 
 It was expected that individuals who have been diagnosed with ADHD and 
receive MBT would report a reduction in inattention and hyperactivity-impulsivity from 
pre- to post-intervention. It was also expected that individuals would report 
improvements in executive functioning from pre- to post-intervention. Several potential 
moderators were also investigated. Firstly, whether age of participants effects treatment 
success was assessed. It was hypothesized that MBT would be more effective in reducing 
ADHD symptoms in adults because as individuals with ADHD age, inattention increases 
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while hyperactivity-impulsivity decreases and research has more often provided evidence 
that MBT reduces inattention, rather than hyperactivity-impulsivity. Secondly, an 
analysis was conducted to determine whether self- and other-informant reported changes 
across these functional domains are consistent. It was hypothesized that self- and other-
informant (e.g., parent or clinician) reports would differ because research has shown 
parents of children with ADHD to be more accurate reporters of symptoms than the child 
or adolescent.  
Methods   
 Meta-analyses were used to summarize data across multiple quantitative studies 
(Lipsey & Wilson, 2001). This statistical technique provides a more systematic, detailed 
analysis of a particular intervention across studies than a more traditional qualitative 
review of the literature (Lipsey & Wilson, 2001). An effect size was calculated for each 
study, and these were pooled to obtain an overall effect size and confidence interval, 
which provided the magnitude of change associated with an intervention. The aim of this 
technique was to estimate the true effect size of the given intervention, rather than the 
effect size provided from a single study, which limits its generalizability. 
Data Sources  
 Studies were collected by searching the following databases: PsychINFO and 
PubMed. The search terms attention-deficit/hyperactivity disorder, and mindfulness, or in 
combination with the abbreviations ADHD, MBSR, MBCT, MBT were used to identify 
studies. The search was performed from the first available date through December 2014. 
The author checked the databases systematically on several occasions to avoid accidental 
omissions. Following the search of the databases, Google Scholar was used to identify 
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any studies that may not have been identified on the databases. References cited in 
articles and dissertations on mindfulness-based therapies and ADHD were reviewed to 
determine if any studies were not identified in the search of the aforementioned 
databases. References cited in MBT reviews and meta-analyses were also searched to 
identify studies that fit inclusion criteria that may not have been identified. 
Corresponding authors of each paper included in the meta-analysis and persons 
conducting research in this area were contacted to address issues of publication bias. The 
following researchers whose papers were included in the current study were contacted to 
request any unpublished data on mindfulness interventions and ADHD: Dr. Saskia Van 
der Oord, Dr. Susan Bogels, Dr. John Mitchell, Dr. Poppy Schoenberg, Dr. Lidia 
Zylowska, Dr. Jill Haydicky, Dr. Eva van de Weijer-Bergsma, and Dr. Andrew Roach. 
Most of the researchers did not have any unpublished data to provide. Two of the 
researchers, Dr. Susan Bogels and Dr. Poppy Schoenberg, reported several manuscripts 
in progress or in press investigating the effectiveness of MBT in large samples of adults 
and adolescents with ADHD, however neither were comfortable releasing the effect size 
data of the unpublished work. Several other researchers and institutes that specialize in 
mindfulness training were contacted for data: Dr. Susan Smalley (UCLA Mindful 
Awareness Research Center), Dr. Kimberly Schonert-Reichl (University of British 
Columbia), and The Centre for Mindfulness Studies (University of Toronto). No 
additional published or unpublished data were collected from these sources due to 
unavailability or reluctance to release unpublished data.  
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Inclusion and Exclusion Criteria 
 Studies examining the pre-post or controlled effects of MBT on individuals – both 
adults and children – diagnosed with ADHD are considered for the analysis. Studies were 
excluded if they (1) did not include a mindfulness-based intervention, (2) examined 
mindfulness as a component of another therapy (i.e. mindfulness was not the central 
component of the therapy), (3) did not aim to look at treatment effects, (4) examined the 
non-direct effect of mindfulness (e.g. effects of mindfulness on therapists or parents of 
children with ADHD), (5) reported no clinical outcomes, (6) reported insufficient 
information to compute effect size, (7) reported data that overlapped with previous 
studies, or (8) used protocols that involved other forms of meditation. Studies will be 
limited to those in the English language. The first author determined eligibility in a non-
blinded standardized manner.  
Data Extraction 
Following the collection of all eligible studies the following information was 
extracted: (1) participant characteristics (e.g. mean age, gender distribution, diagnosis); 
(2) control group characteristics, if applicable (e.g. number of control participants, mean 
age, gender distribution, type of control, type of treatment); (3) treatment characteristics 
(e.g. type of mindfulness intervention, length of intervention, therapist qualification); (4) 
the study characteristics (e.g. date of publication, design, number of participants, outcome 
measure used, follow-up length); (5) and treatment effects on outcome measures of 
attention, hyperactivity-impulsivity, and executive functions (e.g., means and standard 
deviations). The treatment effects of MBT on ADHD symptomology were measured by 
the following outcome measures: attention and hyperactivity-impulsivity. A qualitative 
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review was also conducted to determine the effects of MBT on executive functioning in 
individuals with ADHD.  
Summary Measures 
Each study included in the meta-analyses measured changes in inattention, 
hyperactivity-impulsivity, and executive functioning using parental-, teacher-, and self-
report ratings. Many of the studies used similar measures. A brief review of the measures 
used and their psychometric properties is reported below. 
 ADHD Symptoms: Inattention & Hyperactivity-Impulsivity 
ADHD Rating Scale-IV. The ADHD Rating Scale-IV (ADHD-RS-IV, DuPaul et 
al. 1998) is a scale originally designed for children and adolescents, however has been 
employed in studies with adult samples. The scale is an 18-item informant-based scale 
that assesses the 18 symptoms from the DSM-IV used to diagnose ADHD. Each item is 
rated from 0 (never or rarely) to 3 (very often). The scale has been shown to have good 
internal consistency and high agreement between raters, with raters scoring individuals 
with the same total score 65% of the time (Adler et al., 2005). 
 The Behaviour Assessment System for Children, Second Edition (BASC-2). The 
BASC-2 (Reynolds & Kamphaus, 2004) consists of both parent and teacher ratings of 
behavioural and personality characteristics (e.g., attention problems, hyperactivity, 
activities of daily living). Chronbach’s alpha revealed an internal consistency of .90 for 
the composite scales. Test-retest reliability correlations are between .80 and .89 for 
composite scores. The BASC-2 has strong correlations with other ADHD rating scales, 
such as the ABAS Child Behavior Checklist for Ages 1-5, the Conners’ Parent Rating 
Scale- Revised, the Behavior Rating Inventory of Executive Functioning (BRIEF). 
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Child Behavior Checklist & Youth Self Report. The Child Behaviour Checklist 
(CBCL; Achenbach, 2001) is an informant-based rating scale of emotional and 
behavioural problems, social skills, and academic skills created for the assessment of 
children. The Youth Self Report (YSR; Achenbach, 2001), which is based off the CBCL, 
is a self-based rating scale used to assess internalizing and externalizing problems, and 
behavioural and emotional functioning. Both the CBCL and YSR have been shown to 
have good reliability and validity. 
 Conners 3rd Editiion. The Conners 3-P is used to screen for ADHD in both 
adolescents and children. Both the Conners 3-P, which is the parental-report and the 
Conners 3-SR, which is the adolescent self-report were used in the included studies. 
These measures assess ADHD symptoms (i.e. Inattention and Hyperactivity-Impulsivity), 
learning problems, aggression, oppositionality, and relationship problems. Reliability 
coefficients range from 0.85 to 0.97, test-retest correlations range from 0.72 to 0.98 for 
each scale (Conners, 2008). 
 Current ADHD Symptoms Scale. This measure of ADHD symptoms measures 
the 18 DSM-IV symptoms of ADHD, as well as 10 domains that could be affected by 
these symptoms in day-to-day functioning (Barkley & Murphy, 2006). Severity of 
symptoms is assessed on a four point likert scale from 1 (not all or rarely) to 4 (very 
often).  
 Disruptive Behaviour Disorder Rating Scale (DBDRS). The DBDRS (Pelham et 
al., 1992) is a 45-item scale that contains four subscales that assess inattention, 
hyperactivity-impulsivity, ODD, and CD. Each item is assessed on a likert scale ranging 
from 0 (not at all) to 3 (Very much). The scale has been shown to have good reliability 
  
 
27
and validity (Massetti, Pelham, & Gnagy, 2005; Owens & Hoza, 2003; Pelham et al., 
2005). Internal consistency reliabilities range from .94 to .97.  
 Swanson, Nolan, and Pelham Scale (SNAP-IV; adolescents). The SNAP-IV 
(Swanson, 1995) is a measure of severity of the 18 DSM-IV criteria of ADHD. It 
assesses inattention and hyperactivity-impulsivity, as well as symptoms of ODD. Each 
item is rated on a likert scale from 0 (no, not at all) to 3 (much). The SNAP-IV has been 
shown to have good internal consistency (Stevens, Quittner, & Abikoff, 1998). However, 
parental and teacher agreement has been reported as poor (Swanson et al., 2001). 
 Executive Functioning. 
Behavioural Rating Inventory of Executive Function (BRIEF). The BRIEF 
(Goia et al., 2000) is an 86-item measure that consists of eight scales that measure 
different aspects of executive functioning: inhibit, shift, emotional control, initiate, 
working memory, plan/organize, organization of materials, and monitor. The eight scales 
provide two index scores: Metacognition and Behavioural Regulation.  The scale has 
good internal consistency for parent and teacher reports (alpha level of .93 to .97) and 
adequate test-retest reliability (r = .74 to .95). Parent test-retest correlation across the 
scales was .81 (Goia et al., 2000). 
Conners 3rd Editiion. The Conners 3-P is a parental rating scale of ADHD 
symptoms that includes a scale assessing executive functioning, which was used for one 
of the included studies for the evaluation of changes in executive functioning. See above 
for review of psychometric properties.  
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Analyses 
Following the collection of all published and unpublished data that met the 
inclusion criteria, the data were synthesized to estimate the overall effect size. Effect 
sizes (Cohen’s d) were computed using the means, standard deviations, sample size and 
correlation of the pre- and post-measures for each outcome and informant, for each of the 
individual studies in order to compare the magnitude of change associated with 
mindfulness-based interventions. The standardized difference in means was computed 
using the following formula: 
𝑑 =    𝑌!"##𝑆!"#!!"   = 𝑌! − 𝑌!𝑆!"#!!"  
The standard deviation within groups was computed from the standard deviation 
of the difference, using the following formulas: 
𝑆  !"#!!" = 𝑆!"##2(1− 𝑟) 
where the standard deviation of the difference scores (Sdiff) was calculated as: 
𝑆!"## =   𝑆𝐷!! + 𝑆𝐷!! − 2  ×  𝑟  ×  𝑆𝐷!  ×  𝑆𝐷! 
where r is the the pretest-posttest correlation. In within-group analyses the correlation 
between pre- and post- measures was taken into account when calculating effect sizes 
because the two groups were not independent. When the correlations between the pre- 
and post-treatment measures were not available a conservative estimate, recommended 
by Rosenthal (1993), was used (r = .7). The standard deviation of the difference scores 
was used to calculate the standard deviation within because if the sample displays a wide 
range of symptoms before treatment the calculated effect size would be lower if just the 
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pretreatment standard deviation is used to calculate effect size. If the pretreatment 
standard deviation is low and symptoms have low variability than the effect size may be 
overestimated. Using the standard deviation of difference rather than the standard 
deviation of pretreatment scores changes the focus from pre-treatment variability to the 
variability in how much change clients experience over the course of the treatment 
(Siedel, Miller, & Chow, 2013). The variance was calculated as: 
𝑉! = 1𝑛 + 𝑑!2𝑛 2(1− 𝑟) 
where n is the sample size of the study. The previously mentioned formulas were used to 
calculate effect size and variance for both attention and hyperactivity-impulsivity, for 
each informant reported by each study.  
Next, the primary analyses were conducted examining the overall effects of MBT 
on ADHD symptomology separately (i.e. attention and hyperactivity-impulsivity). 
Effects based on more than one informant (e.g., self and parent) were combined (or 
averaged) to obtain a single effect size estimate to be used in the full model. A composite 
effect size was computed for each study that included more than one informant report 
using the following formula: 
𝑑!"#$"%&'(   = 12 (d! + 𝑑!) 
Thus each study only contributed a single effect size to the primary analysis. The 
variance for the composite effect size was computed taking into account both the 
individual informants variance and the correlation between informant reports using the 
following equation: 
𝑉!  !"#$"%&'( = 14 (𝑉!! + 𝑉!! + 2𝑟 𝑉!!     𝑉!!)   
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Because the correlation between these outcomes is not often reported within the studies, 
the conservative value of 1.00 will be used, which may overestimate variance and 
underestimate precision. After calculating the composite Cohen’s d and its associated 
variance for each individual study and each outcome of interest, these effect size 
estimates were aggregated to obtain an overall (or summary) effect size with its 
associated 95% CI, Z, and p value. 
Because the participants and interventions differed across studies, a random 
effects model was applied in order to take into account the between study and within 
study variability when aggregating the effect sizes (Hunter & Schmidt, 2004). In a 
random effects model it is assumed that variation occurs from two sources: sampling 
variation that occurs because each study used a different sample of participants and 
random variation that occurs because the effect sizes contributed from each study are 
sampled from a population of effect sizes. Whereas, in a fixed-effect model it is assumed 
that each effect size is the estimate of one true population effect and the effect sizes 
contributed from each study only differ due to sampling error. In this analysis, a fixed 
effect model would not be justified because the goal was not to estimate one true effect 
size; rather the goal was to estimate the mean distribution of effect sizes across studies 
with various participant and intervention characteristics (Borenstein et al., 2010). Further, 
in a fixed effect model large studies are given a much higher relative weight in the 
analysis because it is assumed that these studies provide more information about the true 
effect size because all studies are presumed to be the same. In a random effects model the 
relative weight assigned to each study is in a more narrow range because the relative 
weight of each study is less affected by sample size. Thus, using a random effects model 
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allows the meta-analyst to make generalizations that extend beyond the samples used in 
the specific analysis (Hunter & Schmidt, 2004).  
After aggregating the effect sizes, a test of homogeneity was conducted to 
determine if the overall effect size is a result of the intervention or if other possible 
factors have influenced the relationship. Heterogeneity was assessed using the I2 and chi-
squared statistic (Q). The Q test informs the researcher whether heterogeneity is present. 
The I² describes the percentage of variation across studies that is due to real differences 
between the studies (e.g., methodology) and is not affected by low statistical power 
(Higgins and Thompson, 2002; Higgins et al., 2003). If significant heterogeneity is 
found, the relationship between the variables may be influenced by moderating variables. 
Higgens et al. (2003) suggests an I2 of 25%, 50%, and 75% would indicate low, 
moderate, and high homogeneity, respectively, and the Q test produces a p value to 
indicate the presence of significant heterogeneity. All statistical analyses were conducted 
using Comprehensive Meta-analysis Software (CMA). 
Subgroup analysis 
 Many of the studies reported both self and other informant ratings for ADHD 
symptoms; other ratings refer to ratings obtained from the participant’s parents or teacher. 
Thus, in addition to calculating the effect size of the composite scores across informant 
ratings, a subgroup analysis was conducted for self- versus other-ratings to determine if 
effect sizes differ across informant type and if type of informant contributed to any 
heterogeneity found within the analysis. 
 Another variable that may have contributed to heterogeneity between the studies 
was age because individual studies included both child and adult populations. However, a 
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subgroup analysis was not conducted for child versus adult populations to determine if 
effect sizes differ across age group, or to determine if age of participants contributes to 
any heterogeneity found within the analysis because only one study included in the 
analysis (Mitchell et al., 2013) measured the effects of MBT in an adult sample. The 
subgroup analysis was also conducted using CMA. 
Publication bias 
 One limitation of conducting meta-analyses was the risk of publication bias, 
which is the misleading bias of published data due to the fact that studies with significant, 
positive results are more likely to be published. This can be problematic for systematic 
reviews and meta-analyses because the reviews will be inherently biased if the studies 
used are unrepresentative of all the existing literature. In order to address the possibility 
of publication bias, individuals conducting research in this field were contacted in order 
to collect any unpublished datasets that may be available. Following these efforts, 
publication bias was assessed by statistical analyses. As recommended by Sterne, Egger, 
& Smith (2001), funnel plots were created to statistically test for publication bias. The 
funnel plot included the measure of treatment effect on the horizontal axis and the 
standard error on the vertical axis, which allowed the researcher to determine the region 
in which the points should fall if publication bias is not present. An asymmetric funnel 
indicates potential publication bias because it would show most studies falling into one 
side of the funnel with either positive or negative EF. Given that the previous method can 
perform poorly with small and heterogeneous samples, ‘fail-safe-N’ was also be 
calculated. This statistic estimates the number of studies with null results required to 
reduce the effect size to non-significance. 
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 Further, to address concerns of publication bias, the ‘trim and fill’ method was 
used to correct asymmetry caused by publication bias in the funnel plots (Taylor, 1998, 
Duval, 2000). This method removes small studies that are causing asymmetry in the plot 
and creates a new funnel plot using an iterative process to replace omitted studies around 
the center of the funnel plot to estimate the true center of the plot. This technique 
provides an estimate of the number of missing studies and an adjusted effect size based 
on the imputed values.  
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III. RESULTS 
 The literature search of PsycINFO produced 45 studies and the search of PubMed 
produced 18 studies, including 8 dissertations and 8 books. Upon immediate evaluation 
29 publications were eliminated (8 books, 4 reviews, 5 qualitative studies, 1 collection of 
abstracts, and 11 duplicate studies). After reviewing the abstracts of the 34 remaining 
studies, 24 studies were eliminated (4 reviews, 1 qualitative article, 5 journals with no 
MBT, 5 studies with no ADHD group, 5 studies with neither an ADHD group or a MBT, 
1 study that did not measure core symptoms of ADHD, 1 study examining trait 
mindfulness, 1 study examining indirect effects of MBT, and 1 sample that overlapped 
with another study). This process resulted in 10 studies that met the inclusion criteria. 
From these 10 studies that met inclusion criteria, two were excluded from the analysis. 
One study (Sheckler, 2013) was excluded from the analysis because sufficient 
information was not provided in the paper to calculate effect sizes and the researchers did 
not respond to email requests for the information necessary to calculate effect sizes. A 
second study (Schoenberg, 2014) was excluded because it was the only study that 
examined the controlled effects of MBT on ADHD symptoms and therefore could not be 
included in the meta-analysis of pre- and post- intervention designs or in a separate meta-
analysis of controlled effects. 
ADHD Symptoms: Inattention and Hyperactivity-impulsivity 
 Eight studies measured the effects of MBT on inattention and combined ratings 
across 74 self-reports and 93 observer-reports of inattention for a total of 167 ratings. The 
overall effect size was calculated at d= -.72 (95% CI [-1.066, -0.373], Z = -4.066, p < 
.001) (see Figure 1). The test of homogeneity of effect size was significant (Q = 26.81, df 
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= 7, p <.001). The I2 statistics indicated high heterogeneity (73.89%), suggesting high 
between study variability.  
 Seven studies measured the effects of MBT on hyperactivity-impulsivity and 
combined ratings across 64 self-reports and 83 observer-reports of hyperactivity-
impulsivity for a total of 147 ratings. The effect size of MBT on hyperactivity-
impulsivity in individuals diagnosed with ADHD at the end of the intervention was 
calculated at d= -.59 (95% CI [-.871, -.311], Z = 4.14, p<.001) (see Figure 2.). The test of 
homogeneity was significant (Q = 13.45, p<.001) indicating the presence of 
heterogeneity. The I2 statistic indicates heterogeneity and was in the moderate range 
(55.46%). 
Subgroup analysis 
 A subgroup analysis was conducted for self - versus observer-ratings for 
inattention (see Figure 3). Seven studies (Carboni, 2012; Haydicky et al., 2013; Mitchell 
et al., 2013; Ryznack, 2011;Van de Weijer-Bergsma et al. 2012; van de Oord et al., 2012; 
Worth, 2013;) reported other observer ratings and five studies reported self-ratings 
(Haydicky et al., 2013; Mitchell et al., 2013; Ryznack, 2011; van de Weijer-Bergsma et 
al., 2012; Zylowska et al., 2008). Effect sizes were calculated for each type of report 
separately. The effect size for self-report (d = -0.71, 95% CI [-1.190, -0.233], z= -2.917 p 
< .01) and other informant report (d = -1.00, 95% CI [-1.433, -0.567], z= -4.530, p < 
.001) subgroups were both significantly different from 0. However, given that the effect 
sizes were similar no moderation was observed. Both the self-report (I2= 81.04) and other 
informant report continued to demonstrate significant heterogeneity (I2=73.08). The test 
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of homogeneity was significant for both self (Q = 21.096, p< .001) and other-ratings (Q = 
22.284, p <.01) indicating the presence of heterogeneity. 
 A subgroup analysis was calculated for self- versus observer-ratings for 
hyperactivity-impulsivity (see Figure 4). Six studies (Carboni, 2012; Haydicky et al., 
2013; Mitchell et al., 2013; Ryznack, 2011; van de Oord et al., 2012; Worth, 2013) 
reported other observer ratings (i.e. parental and teacher) and four studies reported self-
ratings (Haydicky et al., 2013; Mitchell et al., 2013; Ryznack, 2011; Zylowska et al., 
2008;). Effect sizes were calculated for each type of report separately. The effect size for 
both self-report (d = -0.68, 95% CI [-1.121 to -0.244], Z=-3.050, p<.005) and other 
informant report (d = -0.634, 95% CI [-1.010 to -0.258], Z=-3.307, p<.005) were 
significant. However, given that the effect sizes were similar no moderation was 
observed. The test of homogeneity was not significant for other-informant (Q = 8.584 p = 
.127), demonstrating only moderate heterogeneity (I2= 41.751). The test of homogeneity 
was significant for self-ratings (Q = 17.813, p <.01) indicating the presence of 
heterogeneity. The self-report (I2= 83.158) overall effect size estimate continued to show 
significantly high heterogeneity. This could indicate that self-report accounts for more of 
the between study variance. 
 A subgroup analysis was not conducted for adults versus children for either 
outcome of inattention or hyperactivity-impulsivity due to limited data. Only one pre/post 
design study reported findings in a homogenous adult sample; one study reported 
findings from both adult and children together and the remaining studies investigated the 
effects of MBT on children with ADHD. Thus, the question of whether the efficacy of 
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MBT differs in children and adults with ADHD remains unaddressed in the present 
analysis. 
Publication bias and sensitivity analysis 
 The funnel plots, which graphically represent publication bias, did not indicate 
any substantial concerns, however they are difficult to interpret with a small number of 
studies. One study (Mitchell, 2013) within each of the primary analyses was located 
outside of the funnel, with a large negative effect size. The trim and fill technique for 
inattention results in a mean effect size of -.46 (95% CI -0.832 to -0.093) with three 
studies missing. For hyperactivity-impulsivity the trim and fill technique results in a 
mean effect size -0.45 (95% CI -0.769 to -0.122) with two studies missing. Although both 
effect sizes were reduced, they both remained within the moderate range. 
 For the studies investigating inattention and hyperactivity-impulsivity a fail-safe 
N of 110 and 65 studies, respectively, was indicated. This indicates the number of studies 
with non-significant effect size that would be needed to render the current overall 
estimates non-significant. Thus, it is not likely that unpublished data would nullify the 
results of the current meta-analysis. 
 Due to one study of concern displayed on the funnel plot, the researcher 
conducted a sensitivity analysis to determine how the effect size of the overall model of 
attention and hyperactivity-impulsivity would be affected by the removal of that single 
study. To accomplish this the analysis was run multiple times after the removal of each 
single study from the analysis and this produced only marginal differences in effect size. 
However the removal of the study located outside of the funnel (Mitchell et al., 2013) did 
produce some differences for the overall effect size estimate of inattention (d = -0.53, 
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95% CI [-0.763, -0.302], z= -4.53 p < .001) and hyperactivity-impulsivity (d = -0.45, 
95% CI [-0.626, -0.264], z= -4.83 p < .001). Although the overall effect size decreased 
for both outcomes, both remained within the medium size range and significance levels 
were not affected (Cohen, 1992). Of noteworthy change, the heterogeneity for the 
primary analysis of inattention was no longer significant (Q = 10.219, df = 6, p > 0.05) 
and the I2 statistic was reduced from 73.89% to 41.29%. Thus, after removal of this 
single study, the between study variance reduced considerably. Similarly, the 
heterogeneity for the primary analysis of hyperactivity-impulsivity was no longer 
significant (Q = 3.28, df = 5, p > 0.05) and the I2 statistic was reduced to from 62.84% to 
0%. Thus, in the remainder of the studies included in the meta-analysis there was no 
observed heterogeneity caused by between study variance. It is important to note that this 
was the only study in the meta-analysis that consisted of an adult sample. Thus, as per the 
original hypothesis, it is possible that the effect size for adults with ADHD who receive 
MBT is much higher, however as aforementioned, the current limited data does not allow 
for further investigation. The implications of these findings will be discussed below. 
Executive Functioning 
 Four of the studies that met inclusion criteria for the current study reported the 
effects of MBT on executive functioning; however, a meta-analysis was not conduced 
because each study measured executive functioning with a combination of different 
subscales and scales from the BRIEF. Researchers were contacted to obtain the total 
BRIEF scores for each study, but this was unsuccessful, for this reason a qualitative 
review was conducted. The aim of this qualitative review is to evaluate the evidence of 
  
 
39
the efficacy of mindfulness-based therapies in improving executive functioning in 
individuals with ADHD.   
 Haydicky et al., (2013) conducted a non-controlled quasi-experimental design, in 
which 18 adolescents (13 males, M = 15.5; SD =1.58) diagnosed with ADHD and 17 of 
their parents participated in an 8-week mindfulness therapy, MYmind. MYmind is a 
program adapted from MBCT for use with children and adolescents with ADHD. The 
intervention was lead by two doctoral level child clinical psychology graduate students 
who trained in a 12-week mindfulness course for mental health professionals and 
reported their own mindfulness meditation practice. The executive functioning subscale 
on the Conners-3 Parental report were used to measure executive functioning. Parental 
reports of executive functioning were completed by the mothers of the children, with the 
exception of one father report. Participants were assessed at four-time points: baseline, 
pre-intervention, post-intervention, and 6-week follow-up. Results of a one-way repeated 
measures ANOVA demonstrated a significant time effect in executive functioning, 
however post-hoc pairwise comparisons between pre- and post-intervention scores on 
executive functioning were non-significant (p = .527, d = 0.36). 
 The study was limited by small sample size and a non-randomized uncontrolled 
design. Further, research has suggested that parental involvement in treatment can 
increase reported improvements,, thus the involvement of parents in the intervention 
could affect results (Chronis et al., 2006). The researchers noted that 78% of the 
adolescents had a comorbid disorder and 61% of the adolescents were taking medication 
for their ADHD. 
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 Van de Weijer-Bergsma et al., (2012) conducted an uncontrolled trial involving 
10 adolescents aged 11-15 (M = 13.4) diagnosed with ADHD, 19 parents, and 7 tutors, 
investigating the efficacy of an 8-week mindfulness-training program on reducing 
behavioural and attentional problems. The intervention was lead by a cognitive-
behavioural therapist who also had unspecified mindfulness training. Executive 
functioning was assessed with the Behavior Rating Inventory of Executive Function 
(BRIEF; Gioia et al., 2000). The researchers reported the metacognition and behavioural 
regulation scales of the BRIEF separately. Results showed that behavioral regulation did 
not improve significantly according to parents or tutors, however at 8-week follow-up 
fathers reported significant reductions in behavioural regulation. No significant changes 
in metacognition were reported post-intervention by parents or tutors. However, similarly 
to behavioural regulation, at 8-week follow-up fathers reported a significant reduction in 
meta-cognitive problems.  
 This study was also limited by a small sample size and non-randomized design. It 
is important to note that only one adolescent participant was receiving stimulant 
treatment during the course of this intervention. Parents of this study also received a 
Mindful Parenting intervention, and as aforementioned the involvement of parents in the 
intervention could affect results (Chronis et al., 2006). The fathers reported a reduction in 
parenting stress following the Mindful Parenting intervention, and this could have 
affected their reports of improved executive functioning at 8 week follow-up, because 
research has shown that parental stress can affect parent ratings of disruptive behaviours 
(Langberg et al., 2010). 
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 Mitchell et al. (2013) conducted an 8-week randomized within-in wait-list control 
study investigating the efficacy of mindfulness treatment for improving symptoms of 
ADHD, executive functioning, and emotional functioning in a homogenous adult sample, 
aged 18-50. Eleven participants were in the treatment group and nine participants were in 
the waitlist control group. The intervention conducted was Mindful Awareness Practices 
(MAPs), a mindfulness program developed by Zylowska et al., (2008) for individuals 
with ADHD. The intervention was administered by a PhD-level clinical psychologist. 
Executive functioning was assessed with the BRIEF-Adult version (Roth, Isquith, & 
Gioia, 2005) and the Deficits in Executive Functioning Scale (DEFS; Barkley, 2011) self 
and clinician report. Further, participants completed a short battery of laboratory tasks to 
measure components of executive functioning. Results demonstrated that scores on the 
self-reported BRIEF-A (p = .003, d = 1.55), self-reported DEFS (p = .005, d = 1.45), and 
the clinician-rated DEFS (p < .001, d = 2.67) were statistically significant with large 
effect sizes. The researchers conclude that this may indicate that executive functioning in 
the treatment group improved relative to the waitlist control group. However, there was 
no significant difference between the treatment and control group of performance on 
laboratory tasks measuring executive functioning.  
 This study was limited by small sample size, however the use of the waitlist 
control group was an advantage. The study was strengthened by the addition of the 
laboratory tasks to measure executive functioning, however the researchers speculate that 
the discrepancy between findings on self-report improvements and laboratory tasks is that 
the neuropsychological tasks may not capture the executive functioning difficulties that 
these individuals are having in their day-to-day life.  
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 Carboni (2012) conducted a multiple baseline across participant’s design to 
determine the effects of mindfulness on executive functioning. Four eight-year old males 
who had been diagnosed with ADHD participated in the study. The intervention was one-
on-one mindfulness training for 30-45 minutes, twice per week. An interventionist with 
mindfulness training provided the intervention. The researcher used the parent and 
teacher reports of the BRIEF (Gioia et al., 2000) to assess executive functioning in the 
children. The Reliable Change Index (RCI) was calculated to for the Inhibit, Initiate, and 
Monitor scale of the BRIEF to determine if the pre- to posttest change were greater than 
what would be expected just from measurement error. Parent ratings on the inhitbit scale 
of the BRIEF were significantly improved across all participants. Parent ratings on the 
initiate and monitor scales were also significantly improved for participants 3 and 4. On 
teacher ratings of the BRIEF scales, participant 1 demonstrated no significant changes, 
whereas participant 2 had statistically significant improvements on all three scales. 
Teacher reports on the monitor scale of the BRIEF indicated that Participant 3 and 4 had 
clinically significant decreases, further participant 4 had clinically significant 
improvements on the inhibit scale of the BRIEF. Thus, results were variable, however 
changes noted in pre- and posttest ratings suggests that mindfulness based interventions 
may be effective in improving some aspects of executive functioning in children.  
 Executive functions are described as a set of processes involved in maintaining 
information in working memory; initiating, planning, organizing, executing and 
monitoring activities and behaviors; and regulating behaviour and emotional responses to 
situations. Given the impact that deficits in executive functioning have on normal 
functioning it has been suggested that executive functioning deficits in individuals with 
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ADHD are related to functional impairment in these individuals (Barkley, 1997). Barkley 
(1997) describes the difficulties individuals with ADHD experience in sustaining 
attention are related to deficits in the executive functions that assist in self-regulation. 
This difficulty in self-regulation can manifest as being easily distracted and having 
problems with organizing tasks. Further, deficits in executive functioning can also 
manifest as difficulties controlling impulses. These individuals may rush through tasks, 
or speak and act without thinking. Thus, an intervention that targets these executive 
functions may help individuals with ADHD improve daily functioning and quality of life.  
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IV. DISCUSSION 
 The purpose of the current study was to investigate the effects of mindfulness 
therapies on ADHD symptoms (inattention and hyperactivity-impulsivity) using meta-
analysis. Results from the first meta-analysis, which included eight studies, demonstrated 
that MBT significantly reduced inattention in individuals diagnosed with ADHD. The 
subgroup analysis investigating differences between self- and observer-ratings 
demonstrated that MBT reduced inattention in individuals diagnosed with ADHD 
irrespective of reporter. The second meta-analysis included seven studies and 
demonstrated that MBT significantly reduced symptoms of hyperactivity-impulsivity in 
individuals diagnosed with ADHD. Similarly, the subgroup analysis investigating 
differences between self- and observer- ratings found that MBT reduced symptoms of 
hyperactivity-impulsivity in individuals diagnosed with ADHD, irrespective of reporter.  
Thus, it appears that MBT is effective in reducing the core symptoms of ADHD.  
 However, results must be interpreted with caution given the significant 
heterogeneity across the studies included. Potential causes of heterogeneity were first 
investigated via the aforementioned subgroup analyses. These subgroup analyses were 
conducted to determine if the type of informant would make a significant contribution to 
the studies heterogeneity. The first subgroup analysis revealed that the heterogeneity for 
inattention was not affected by informant type. The second subgroup analysis for 
informant type revealed that heterogeneity for hyperactivity-impulsivity was still 
significant for self-informant reports and the I2 statistic indicated high heterogeneity 
(83.16%). Although, heteroegenity was not longer significant for other-informant reports 
the I2 statistic indicated only moderate heterogeneity (41.75%), suggesting self-reported 
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hyperactivity-impulsivity contributed more heterogeneity to the primary analysis. 
Research has shown that parent-reports of impairment across several domains were more 
predictive than self-reports of actual impairment (Barkley, Fischer, Smallish, & Fletcher, 
2002), thus, perhaps other individuals are more accurate reporters of ADHD symptoms 
and therefore less heterogeneity is contributed by these other-informant reports.  
 The second potential source of heterogeneity that was hypothesized at the outset 
of the study was age of participants. It was predicted that adults would have a greater 
reduction in ADHD symptoms following MBT. However, only one study investigated the 
effectiveness of MBT for reducing ADHD symptoms in homogenous adult sample, thus a 
subgroup analysis was not possible. The sensitivity analysis that was conducted by 
removing each study from the analysis one at a time to determine if the overall effect size 
was significantly affected by any one study revealed that one study in particular (Mitchell 
et al., 2013) had a significant impact on overall heterogeneity in both of the primary 
analyses; this was the only study included in the analyses with an all-adult sample. 
Following removal of this study, heterogeneity was reduced for both inattention, from an 
I2 value of 77.18% to 46.77%, and hyperactivity-impulsivity, from 62.84% to 0%. Thus, 
removal of this study reduced heterogeneity of the primary analysis of inattention from 
high to moderate levels, and reduced heterogeneity to non-significance in the primary 
analysis investigating hyperactivity-impulsivity, which could indicate a difference in the 
effectiveness of MBT in treating ADHD symptoms in adults and children.   
 The effect size for reduction in inattention and hyperactivity-impulsivity in this 
study of adults was considerably larger than the other studies. A possible explanation for 
the larger effect of MBT in adults with ADHD could be influenced by how the symptoms 
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of ADHD change over developmental periods. Specifically, as individuals with ADHD 
get older, symptoms of inattention become more prominent and hyperactivity-impulsivity 
tends to decrease, and there is much more literature to support increased attentional 
capacity following mindfulness training in healthy participants (Lutz et al., 3009; Tang et 
al., 2007) than decreased hyperactivity-impulsivity. Further, adults who are more 
inattentive may find environmental supports and modifications for those problems more 
readily than children and benefit more from mindfulness training than children. The 
findings that the effect size of MBT in reducing ADHD symptoms was larger in the study 
with adult participants and was causing a large amount of the heterogeneity provide 
preliminary support for the hypothesis that MBT may be more effective in reducing 
symptoms of ADHD in adults. Another possible explanation for the larger effect size in 
adults could be a result of adults having more insight into their symptoms and reduction 
in symptoms following treatment. As aforementioned, parental-reports of child ADHD 
symptoms and impairment is more predictive of actual impairment than the child’s self-
reported symptoms and impairment, and research shows that adult self-reported 
symptoms of ADHD were found to correlate significantly with observer reports (Murphy 
& Schachar, 2000). Thus, adults may have more insight into their symptoms and as a 
result report more reductions in symptoms following treatment. Given the limited data on 
adults in the current literature, a subgroup analysis could not be conducted and the 
hypothesis could not be tested. Although, the researcher attempted to account for 
heterogeneity with a sensitivity analysis, it is difficulty to determine whether age of 
participants was the exact source of heterogeneity produced by the study. Further 
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investigation into the effectiveness of MBT in adult versus childhood ADHD is 
warranted.  
 The aforementioned findings of the efficacy of mindfulness based interventions in 
improving executive functioning in individuals diagnosed with ADHD is mixed. The 
studies were limited by small sample sizes and nonrandomized, uncontrolled designs. 
Further investigation into the effectiveness of this intervention in improving executive 
functioning is warranted. Future research would be improved by conducting controlled 
studies and including laboratory tasks of executive functioning, as well as self- and 
observer-reports.  
 Surprisingly few studies measured pre- and post-intervention levels of 
mindfulness (van der Weijer-Bergsma et al., 2012 & Worth, 2013), thus a meta-analysis 
of effect size was not conducted. Given that only two studies reported mindfulness pre- 
and post-intervention the researcher cannot determine whether there were increases in 
mindfulness, whether increases in mindfulness moderated the effects of MBT in reducing 
ADHD symptoms, and thus whether the effectiveness of the therapy is a result of the 
mindfulness component. However, preliminary research has shown support for the 
mindfulness component of MBT as a mechanism of change (Khoury et al., 2013). In 
future investigations of ADHD and MBT it will be important for researchers to assess 
pre- and post-intervention levels of mindfulness to further explore the relationship 
between mindfulness and observed decreases in ADHD symptoms.  
 One study also measured the impact of parental mindfulness training on pre- and 
post-intervention levels of mindfulness of parents who have children with ADHD who 
were receiving MBT to treat the child’s ADHD. It is possible that if parental mindfulness 
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training is successful in increasing levels of mindfulness this could affect parental reports 
of the child’s ADHD symptoms. Effect sizes for parental report on inattention and 
hyperactivity-impulsivity in this study were not largely different from the overall effect 
size reported by other studies in which the parents did not receive the mindful parent 
training, suggesting in this particular study that parental mindfulness training did not 
largely influence observer ratings of children with ADHD. However, it would be 
important to investigate possible influences of parental mindfulness training on ADHD 
symptom reports. 
 The present study is, of course, not without limitations. First, there is a risk of 
publication bias when conducting meta-analysis, which is a misleading bias of published 
data due to the fact that studies with significant, positive results are more likely to be 
published. Although the tests used to detect publication bias did not show evidence of 
significant publication bias, they tend to perform poorly in small samples. However given 
a high ‘fail-safe N’ it is not likely the effect size would be effected by a small number of 
unpublished non-significant studies and although the effect size was reduced by the trim 
and fill techniques, intervention effects were still moderate in size. Another limitation of 
the present study was that the researchers were unable to examine the controlled effects 
of MBT on ADHD symptoms given the limited number of studies with this 
methodological rigor that met inclusion criteria. Lastly, the sample size was small, 
reducing the power of the meta-analysis. However, a meta-analysis can be conducted on 
as few as two studies (Valentine, Pigott, & Rothsein, 2010). Further, several goals can be 
accomplished with meta-analyses; a meta-analysis can be used to determine the 
magnitude of an effect, investigate whether current literature is homogenous, and lastly, 
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if there is heterogeneity what variables can account for this variation and moderate the 
effects (Huedo-Medina, Sánchez-Meca, Marín-Martínez, & Botella, 2006). Thus, despite 
the small sample size the analysis suggested preliminary findings in support of MBT as a 
treatment for reducing ADHD symptoms and can be used to guide future research in this 
area. 
 The present study provides preliminary evidence for the efficacy of MBT in 
ADHD by providing a quantitative review of the current research. The present study can 
help to guide future research, by bringing attention to the need for more methodologically 
rigorous experimental studies to provide more evidence for the use of MBT in individuals 
with ADHD. Further research would allow for investigation into the variables and 
characteristics that moderate the effectiveness of MBT in reducing symptoms of ADHD 
and to address whether this treatment is more effective for individuals with ADHD at 
different developmental stages or with different subtypes of ADHD. 
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